Livzon Pharmaceutica...
SZSE:000513
¥ 34,07
+ ¥0,85 (2,56%)
34,07 ¥
+¥0,85 (2,56%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

¥0,00
Earnings Per Share
¥13,54
Revenue Per Share
65,60%
Gross Margin %
¥27,23 B
Market Cap
¥0,75 B
Long-Term Debt
Earnings Per Share
¥0,00
Revenue Per Share
¥13,54
Gross Margin %
65,60%
Market Cap
¥27,23 B
Long-Term Debt
¥0,75 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2010 2009 2008 2007
EPS Earnings Per Share ¥2,27 ¥2,24 ¥2,10 ¥2,04 ¥1,90 ¥1,83 ¥1,39 ¥1,16 ¥8,06 ¥0,90 ¥0,73 ¥0,61 ¥0,57 ¥0,52 ¥0,49 ¥0,56 ¥0,06 ¥0,58
Earnings Earnings ¥2,02B ¥2,04B ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
RPS Revenue Per Share ¥13,54 ¥13,00 N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Revenue Revenue ¥12,02B ¥11,81B ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
OCF Operating Cash Flow ¥3,15B ¥2,98B ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
FCF Free Cash Flow ¥2,00B ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M
OM Operating Margin 21,85% 21,47% 15,46% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 65,60% 64,03% 61,61% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share ¥2,88 ¥2,62 ¥2,61 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00 ¥0,00
LT Debt Long-Term Debt ¥749,36M ¥1,47B N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 887,91M 908,91M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M 0M
×